RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Olorunseun Ogunwobi to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Olorunseun Ogunwobi has written about Drug Resistance, Neoplasm.
Olorunseun Ogunwobi
Connection Strength
0.765
Drug Resistance, Neoplasm
  1. Harricharran T, Ogunwobi OO. Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2020 Apr; 19(2):175-180.
    View in: PubMed
    Score: 0.613
  2. Pal G, Huaman J, Levine F, Orunmuyi A, Olapade-Olaopa EO, Onagoruwa OT, Ogunwobi OO. Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells. Genes (Basel). 2019 11 22; 10(12).
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support